Data support the use of percutaneous cryoablation and radiofrequency ablation for small renal tumors.
Radiofrequency ablation (RFA) can effectively treat small benign tumors in a single session, and long-term outcomes of RFA for renal tumors depend on tumor size, according to the findings of two studies.
In appropriately selected patients, radiofrequency ablation (RFA) is an effective minimally invasive treatment for cT1a renal cell carcinoma (RCC) that offers long-term oncologic outcomes comparable to nephron-sparing surgery, data show.
Radiofrequency ablation of small renal tumors in otherwise healthy patients preserves renal function.
WASHINGTON, D.C.—A "halo sign" is a common delayed finding following radiofrequency ablation (RFA) of kidney tumors, according to researchers at the University of Toronto.
CT-guided percutaneous radiofrequency ablation (RFA) is safe and effective for treating small biopsy-proven renal tumors, according to researchers.
Radiofrequency ablation (RFA) of small renal tumors is a promising alternative to surgery, investigators in Poland report.
Renal and Urology News Articles
- For Treating Uremic Pruritus, Evidence is Strongest for Gabapentin
- IgG-Degrading Enzyme Desensitizes, Permits HLA-Incompatible Transplant
- Evaluating Practice Options in the Shifting Health Care Landscape
- Melanoma Risk Higher in Kidney Transplant Recipients
- Not All High-Risk Prostate Cancers Are the Same
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)